Viewing Study NCT04337112


Ignite Creation Date: 2025-12-26 @ 10:46 PM
Ignite Modification Date: 2025-12-26 @ 10:46 PM
Study NCT ID: NCT04337112
Status: APPROVED_FOR_MARKETING
Last Update Posted: 2020-08-18
First Post: 2020-04-02
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: The Expanded Access Use of Viltolarsen in Duchenne Muscular Dystrophy With Confirmed Exon 53 Amenable Mutation
Sponsor: NS Pharma, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module